EUVIMEDEUVIMED entdecken
Open Access

S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages

Qiankun Ji, Zibo Li, Yazhou Guo, Xiaoyang Zhang

Aging · 2024

DOI: 10.18632/aging.205949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Qiankun Ji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Zhoukou Central Hospital, Zhoukou, Henan 466000, P.R. China. Hauptthemen laut MEDLINE: Glioblastoma, Calgranulin B, Cell Movement, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCalgranulin BCell MovementMacrophagesImmunotherapyBrain NeoplasmsHumansPrognosisCell Line, TumorDisease ProgressionCell ProliferationBiomarkers, TumorMaleFemaleTumor MicroenvironmentComputational Biology

Stichwörter der Autor:innen

M2 macrophagesS100A9bioinformaticsglioblastoma (GBM)tumor microenvironment

Substanzen

Calgranulin BS100A9 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Zhoukou Central Hospital, Zhoukou, Henan 466000, P.R. China.

Zitieren

APA

Ji, Q., Li, Z., Guo, Y., & Zhang, X. (2024). S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages. Aging. https://doi.org/10.18632/aging.205949

Vancouver

Ji Q, Li Z, Guo Y, Zhang X. S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages. Aging. 2024. doi:10.18632/aging.205949

BibTeX
@article{Ji2024,
  author = {Ji, Qiankun and Li, Zibo and Guo, Yazhou and Zhang, Xiaoyang},
  title = {S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205949}
}
Kostenlos starten →